Clonal dominance defines metastatic dissemination in pancreatic cancer

April 19, 20242 min
Doctor with human Pancreatitis anatomy model with Pancreas

Cancers progress and continuously adapt, making them challenging to treat. As cancer cells replicate and evolve, distinct cellular lineages, or subclones, compete to dominate and drive tumor progression. Researchers led by I-Lin Ho, Ph.D., and Andrea Viale, M.D., developed a new model for pancreatic cancer to study subclone evolution within tumors and metastases. They found that subclones undergo continuous fluctuations in representation during tumor growth, even without any external treatment, with dominant subclones suddenly collapsing and being replaced by others.

Most of these lineages were found in distant organs, even in tumors that did not metastasize. This suggests tumor dissemination is a nonspecific, widespread behavior of tumor cells and challenges the current metastatic cascade model. The results show that the fitness of a subclone within the primary lesion determines whether it disseminates and initiates a tumor at a secondary site. The researchers identified a specific molecular signature for a subset of cells within the tumor capable of sustaining tumor metastases, which could be a potential tool for patient risk stratification.

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives